Sun, Y.; Liu, B.; Loh, H.; Mathialagan, S.; Lin, C.H.-T.; Tarabichi, Y.; Veccia, D.; Wong, R.; Tse, W.; Song, G.
Glucagon-like Peptide-1 Receptor Agonists Are Not Associated with Increased Risk of Acute Pancreatitis or Pancreatic Complications, Including Pancreatic Cancer, in Type 2 Diabetes: A Global Propensity-Matched Cohort Study. J. Pers. Med. 2026, 16, 478.
https://doi.org/10.3390/jpm16090478
AMA Style
Sun Y, Liu B, Loh H, Mathialagan S, Lin CH-T, Tarabichi Y, Veccia D, Wong R, Tse W, Song G.
Glucagon-like Peptide-1 Receptor Agonists Are Not Associated with Increased Risk of Acute Pancreatitis or Pancreatic Complications, Including Pancreatic Cancer, in Type 2 Diabetes: A Global Propensity-Matched Cohort Study. Journal of Personalized Medicine. 2026; 16(9):478.
https://doi.org/10.3390/jpm16090478
Chicago/Turabian Style
Sun, Yan, Benjamin Liu, Hanyou Loh, Samantha Mathialagan, Cindy Hsin-Ti Lin, Yasir Tarabichi, Donovan Veccia, Richard Wong, William Tse, and Gengqing Song.
2026. "Glucagon-like Peptide-1 Receptor Agonists Are Not Associated with Increased Risk of Acute Pancreatitis or Pancreatic Complications, Including Pancreatic Cancer, in Type 2 Diabetes: A Global Propensity-Matched Cohort Study" Journal of Personalized Medicine 16, no. 9: 478.
https://doi.org/10.3390/jpm16090478
APA Style
Sun, Y., Liu, B., Loh, H., Mathialagan, S., Lin, C. H.-T., Tarabichi, Y., Veccia, D., Wong, R., Tse, W., & Song, G.
(2026). Glucagon-like Peptide-1 Receptor Agonists Are Not Associated with Increased Risk of Acute Pancreatitis or Pancreatic Complications, Including Pancreatic Cancer, in Type 2 Diabetes: A Global Propensity-Matched Cohort Study. Journal of Personalized Medicine, 16(9), 478.
https://doi.org/10.3390/jpm16090478
